Compile Data Set for Download or QSAR

Found 1029 hits of ec50 for UniProtKB: P31391   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311957 (US10166214, Example 93 | US10675268, Example 93 | ...) Show SMILES Cc1cccc2c(n[nH]c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.100	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311970 (US10166214, Example 106 | US10675268, Example 106) Show SMILES Cn1nc(c2cccc(Cl)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H21ClN4O/c1-17(2,20-16(23)13-10-7-19-8-11(10)13)15-9-5-4-6-12(18)14(9)22(3)21-15/h4-6,10-11,13,19H,7-8H2,1-3H3,(H,20,23)/t10-,11+,13+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.100	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311957 (US10166214, Example 93 | US10675268, Example 93 | ...) Show SMILES Cc1cccc2c(n[nH]c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.100	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311970 (US10166214, Example 106 | US10675268, Example 106) Show SMILES Cn1nc(c2cccc(Cl)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H21ClN4O/c1-17(2,20-16(23)13-10-7-19-8-11(10)13)15-9-5-4-6-12(18)14(9)22(3)21-15/h4-6,10-11,13,19H,7-8H2,1-3H3,(H,20,23)/t10-,11+,13+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.100	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50597579 (CHEMBL5197201) Show SMILES Clc1cccc(Cc2nnc(Cc3c[nH]c4ccccc34)n2CCCc2c[nH]cn2)c1 Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	0.100	n/a	n/a	n/a	n/a
TBA									Citation and Details Article DOI: 10.1039/d1md00044f BindingDB Entry DOI: 10.7270/Q21C21X0
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM506557 (US11045457, Example 157) Show SMILES Cc1ccccc1[C@@H]1CNCC[C@H]1NC(=O)C(C)(C)COc1ncccc1C(F)(F)F |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.126	n/a	n/a	n/a	n/a
TBA					Assay Description This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...				Citation and Details BindingDB Entry DOI: 10.7270/Q2CN7721
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM506589 (US11045457, Example 190) Show SMILES C[C@H]1CNCC[C@@H]1NC(=O)C(C)(C)COc1ccccc1Cl |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.158	n/a	n/a	n/a	n/a
TBA					Assay Description This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...				Citation and Details BindingDB Entry DOI: 10.7270/Q2CN7721
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311971 (US10166214, Example 107 | US10675268, Example 107 ...) Show SMILES Cc1cccc2c(nn(C)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C18H24N4O/c1-10-6-5-7-11-15(10)22(4)21-16(11)18(2,3)20-17(23)14-12-8-19-9-13(12)14/h5-7,12-14,19H,8-9H2,1-4H3,(H,20,23)/t12-,13+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.200	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50597589 (CHEMBL5209180) Show SMILES COc1ccccc1Cc1nnc(Cc2c[nH]c3cc(F)ccc23)n1CCCc1c[nH]cn1 Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	0.200	n/a	n/a	n/a	n/a
TBA									Citation and Details Article DOI: 10.1039/d1md00044f BindingDB Entry DOI: 10.7270/Q21C21X0
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM523757 (US11136312, Compound MM-I-87) Show SMILES Fc1ccc2c(Cc3nnc(Cc4cccc(c4)C(F)(F)F)n3CCCc3c[nH]cn3)c[nH]c2c1 Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	0.200	n/a	n/a	n/a	n/a
TBA									Citation and Details Article DOI: 10.1039/d1md00044f BindingDB Entry DOI: 10.7270/Q21C21X0
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311971 (US10166214, Example 107 | US10675268, Example 107 ...) Show SMILES Cc1cccc2c(nn(C)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C18H24N4O/c1-10-6-5-7-11-15(10)22(4)21-16(11)18(2,3)20-17(23)14-12-8-19-9-13(12)14/h5-7,12-14,19H,8-9H2,1-4H3,(H,20,23)/t12-,13+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.200	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50597576 (CHEMBL5180543) Show SMILES Clc1ccc(Cc2nnc(Cc3c[nH]c4ccccc34)n2CCCc2c[nH]cn2)cc1Cl Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	0.300	n/a	n/a	n/a	n/a
TBA									Citation and Details Article DOI: 10.1039/d1md00044f BindingDB Entry DOI: 10.7270/Q21C21X0
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM523756 (US11136312, Compound MM-I-83) Show SMILES Fc1ccc2c(Cc3nnc(Cc4cccc(Br)c4)n3CCCc3c[nH]cn3)c[nH]c2c1 Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	0.300	n/a	n/a	n/a	n/a
TBA									Citation and Details Article DOI: 10.1039/d1md00044f BindingDB Entry DOI: 10.7270/Q21C21X0
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311944 (US10166214, Example 80 | US10675268, Example 80 | ...) Show SMILES Cc1ncc(c2ccccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C19H23N3O/c1-11-12-6-4-5-7-13(12)16(10-21-11)19(2,3)22-18(23)17-14-8-20-9-15(14)17/h4-7,10,14-15,17,20H,8-9H2,1-3H3,(H,22,23)/t14-,15+,17+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.300	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311967 (US10166214, Example 103 | US10675268, Example 103) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1noc2c(Cl)cccc12 |r| Show InChI InChI=1S/C16H18ClN3O2/c1-16(2,19-15(21)12-9-6-18-7-10(9)12)14-8-4-3-5-11(17)13(8)22-20-14/h3-5,9-10,12,18H,6-7H2,1-2H3,(H,19,21)/t9-,10+,12+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.300	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311973 (US10166214, Example 109 | US10675268, Example 109) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1n[nH]c2c(F)cccc12 |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.300	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311994 (US10166214, Example 130 | US10675268, Example 130) Show SMILES Cc1nc(n2cccc(C)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C18H24N4O/c1-10-6-5-7-22-15(10)11(2)20-17(22)18(3,4)21-16(23)14-12-8-19-9-13(12)14/h5-7,12-14,19H,8-9H2,1-4H3,(H,21,23)/t12-,13+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.300	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM312007 (US10166214, Example 143 | US10675268, Example 143) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1ncc2c(Cl)cccn12 |r| Show InChI InChI=1S/C16H19ClN4O/c1-16(2,20-14(22)13-9-6-18-7-10(9)13)15-19-8-12-11(17)4-3-5-21(12)15/h3-5,8-10,13,18H,6-7H2,1-2H3,(H,20,22)/t9-,10+,13+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.300	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311944 (US10166214, Example 80 | US10675268, Example 80 | ...) Show SMILES Cc1ncc(c2ccccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C19H23N3O/c1-11-12-6-4-5-7-13(12)16(10-21-11)19(2,3)22-18(23)17-14-8-20-9-15(14)17/h4-7,10,14-15,17,20H,8-9H2,1-3H3,(H,22,23)/t14-,15+,17+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.300	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311967 (US10166214, Example 103 | US10675268, Example 103) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1noc2c(Cl)cccc12 |r| Show InChI InChI=1S/C16H18ClN3O2/c1-16(2,19-15(21)12-9-6-18-7-10(9)12)14-8-4-3-5-11(17)13(8)22-20-14/h3-5,9-10,12,18H,6-7H2,1-2H3,(H,19,21)/t9-,10+,12+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.300	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311973 (US10166214, Example 109 | US10675268, Example 109) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1n[nH]c2c(F)cccc12 |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.300	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311994 (US10166214, Example 130 | US10675268, Example 130) Show SMILES Cc1nc(n2cccc(C)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C18H24N4O/c1-10-6-5-7-22-15(10)11(2)20-17(22)18(3,4)21-16(23)14-12-8-19-9-13(12)14/h5-7,12-14,19H,8-9H2,1-4H3,(H,21,23)/t12-,13+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.300	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM312007 (US10166214, Example 143 | US10675268, Example 143) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1ncc2c(Cl)cccn12 |r| Show InChI InChI=1S/C16H19ClN4O/c1-16(2,20-14(22)13-9-6-18-7-10(9)13)15-19-8-12-11(17)4-3-5-21(12)15/h3-5,8-10,13,18H,6-7H2,1-2H3,(H,20,22)/t9-,10+,13+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.300	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM506615 (US11045457, Example 216) Show SMILES C[C@H]1CNCC[C@@H]1NC(=O)C(F)(F)COc1ccccc1Cl |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.398	n/a	n/a	n/a	n/a
TBA					Assay Description This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...				Citation and Details BindingDB Entry DOI: 10.7270/Q2CN7721
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM312048 (US10166214, Example 184 | US10675268, Example 184) Show SMILES Cc1cccn2c(ccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C18H23N3O/c1-11-5-4-8-21-14(11)6-7-15(21)18(2,3)20-17(22)16-12-9-19-10-13(12)16/h4-8,12-13,16,19H,9-10H2,1-3H3,(H,20,22)/t12-,13+,16+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311992 (US10166214, Example 128 | US10675268, Example 128 ...) Show SMILES Cc1cccn2c(nc(C3CC3)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C20H26N4O/c1-11-5-4-8-24-17(11)16(12-6-7-12)22-19(24)20(2,3)23-18(25)15-13-9-21-10-14(13)15/h4-5,8,12-15,21H,6-7,9-10H2,1-3H3,(H,23,25)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50081058 (CHEMBL3421842 | US10166214, Example 22 | US1067526...) Show SMILES [H][C@@]12CNC[C@]1([H])[C@H]2C(=O)NC(C)(C)c1nc(C)cc2ccccc12 |r| Show InChI InChI=1S/C19H23N3O/c1-11-8-12-6-4-5-7-13(12)17(21-11)19(2,3)22-18(23)16-14-9-20-10-15(14)16/h4-8,14-16,20H,9-10H2,1-3H3,(H,22,23)/t14-,15+,16+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Therachem Research Medilab (India) Pvt. Ltd. Curated by ChEMBL					Assay Description Agonist activity at human somatostatin 4 receptor expressed in H4 cells assessed as inhibition of forskolin-induced intracellular cAMP accumulation i...				ACS Med Chem Lett 6: 110-1 (2015) Article DOI: 10.1021/ml500538a BindingDB Entry DOI: 10.7270/Q2MC91RP
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50081058 (CHEMBL3421842 | US10166214, Example 22 | US1067526...) Show SMILES [H][C@@]12CNC[C@]1([H])[C@H]2C(=O)NC(C)(C)c1nc(C)cc2ccccc12 |r| Show InChI InChI=1S/C19H23N3O/c1-11-8-12-6-4-5-7-13(12)17(21-11)19(2,3)22-18(23)16-14-9-20-10-15(14)16/h4-8,14-16,20H,9-10H2,1-3H3,(H,22,23)/t14-,15+,16+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50081055 (CHEMBL3421843 | US10166214, Example 49 | US1067526...) Show SMILES [H][C@@]12CNC[C@]1([H])[C@H]2C(=O)NC(C)(C)c1nn(C)c2ccccc12 |r| Show InChI InChI=1S/C17H22N4O/c1-17(2,19-16(22)14-11-8-18-9-12(11)14)15-10-6-4-5-7-13(10)21(3)20-15/h4-7,11-12,14,18H,8-9H2,1-3H3,(H,19,22)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311939 (US10166214, Example 75 | US10675268, Example 75) Show SMILES Cn1nc(c2ccc(F)cc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H21FN4O/c1-17(2,20-16(23)14-11-7-19-8-12(11)14)15-10-5-4-9(18)6-13(10)22(3)21-15/h4-6,11-12,14,19H,7-8H2,1-3H3,(H,20,23)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311956 (US10166214, Example 92 | US10675268, Example 92) Show SMILES Cc1cccc2c(noc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H21N3O2/c1-9-5-4-6-10-14(9)22-20-15(10)17(2,3)19-16(21)13-11-7-18-8-12(11)13/h4-6,11-13,18H,7-8H2,1-3H3,(H,19,21)/t11-,12+,13+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311969 (US10166214, Example 105 | US10675268, Example 105) Show SMILES Cn1nc(c2cccc(F)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H21FN4O/c1-17(2,20-16(23)13-10-7-19-8-11(10)13)15-9-5-4-6-12(18)14(9)22(3)21-15/h4-6,10-11,13,19H,7-8H2,1-3H3,(H,20,23)/t10-,11+,13+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311990 (US10166214, Example 126 | US10675268, Example 126 ...) Show SMILES Cc1cccn2c(ncc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H22N4O/c1-10-5-4-6-21-13(10)9-19-16(21)17(2,3)20-15(22)14-11-7-18-8-12(11)14/h4-6,9,11-12,14,18H,7-8H2,1-3H3,(H,20,22)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311992 (US10166214, Example 128 | US10675268, Example 128 ...) Show SMILES Cc1cccn2c(nc(C3CC3)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C20H26N4O/c1-11-5-4-8-24-17(11)16(12-6-7-12)22-19(24)20(2,3)23-18(25)15-13-9-21-10-14(13)15/h4-5,8,12-15,21H,6-7,9-10H2,1-3H3,(H,23,25)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM312048 (US10166214, Example 184 | US10675268, Example 184) Show SMILES Cc1cccn2c(ccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C18H23N3O/c1-11-5-4-8-21-14(11)6-7-15(21)18(2,3)20-17(22)16-12-9-19-10-13(12)16/h4-8,12-13,16,19H,9-10H2,1-3H3,(H,20,22)/t12-,13+,16+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50081058 (CHEMBL3421842 | US10166214, Example 22 | US1067526...) Show SMILES [H][C@@]12CNC[C@]1([H])[C@H]2C(=O)NC(C)(C)c1nc(C)cc2ccccc12 |r| Show InChI InChI=1S/C19H23N3O/c1-11-8-12-6-4-5-7-13(12)17(21-11)19(2,3)22-18(23)16-14-9-20-10-15(14)16/h4-8,14-16,20H,9-10H2,1-3H3,(H,22,23)/t14-,15+,16+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50081055 (CHEMBL3421843 | US10166214, Example 49 | US1067526...) Show SMILES [H][C@@]12CNC[C@]1([H])[C@H]2C(=O)NC(C)(C)c1nn(C)c2ccccc12 |r| Show InChI InChI=1S/C17H22N4O/c1-17(2,19-16(22)14-11-8-18-9-12(11)14)15-10-6-4-5-7-13(10)21(3)20-15/h4-7,11-12,14,18H,8-9H2,1-3H3,(H,19,22)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311939 (US10166214, Example 75 | US10675268, Example 75) Show SMILES Cn1nc(c2ccc(F)cc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H21FN4O/c1-17(2,20-16(23)14-11-7-19-8-12(11)14)15-10-5-4-9(18)6-13(10)22(3)21-15/h4-6,11-12,14,19H,7-8H2,1-3H3,(H,20,23)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311956 (US10166214, Example 92 | US10675268, Example 92) Show SMILES Cc1cccc2c(noc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H21N3O2/c1-9-5-4-6-10-14(9)22-20-15(10)17(2,3)19-16(21)13-11-7-18-8-12(11)13/h4-6,11-13,18H,7-8H2,1-3H3,(H,19,21)/t11-,12+,13+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311969 (US10166214, Example 105 | US10675268, Example 105) Show SMILES Cn1nc(c2cccc(F)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H21FN4O/c1-17(2,20-16(23)13-10-7-19-8-11(10)13)15-9-5-4-6-12(18)14(9)22(3)21-15/h4-6,10-11,13,19H,7-8H2,1-3H3,(H,20,23)/t10-,11+,13+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311990 (US10166214, Example 126 | US10675268, Example 126 ...) Show SMILES Cc1cccn2c(ncc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H22N4O/c1-10-5-4-6-21-13(10)9-19-16(21)17(2,3)20-15(22)14-11-7-18-8-12(11)14/h4-6,9,11-12,14,18H,7-8H2,1-3H3,(H,20,22)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50081055 (CHEMBL3421843 | US10166214, Example 49 | US1067526...) Show SMILES [H][C@@]12CNC[C@]1([H])[C@H]2C(=O)NC(C)(C)c1nn(C)c2ccccc12 |r| Show InChI InChI=1S/C17H22N4O/c1-17(2,19-16(22)14-11-8-18-9-12(11)14)15-10-6-4-5-7-13(10)21(3)20-15/h4-7,11-12,14,18H,8-9H2,1-3H3,(H,19,22)/t11-,12+,14+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	0.400	n/a	n/a	n/a	n/a
Therachem Research Medilab (India) Pvt. Ltd. Curated by ChEMBL					Assay Description Agonist activity at human somatostatin 4 receptor expressed in H4 cells assessed as inhibition of forskolin-induced intracellular cAMP accumulation i...				ACS Med Chem Lett 6: 110-1 (2015) Article DOI: 10.1021/ml500538a BindingDB Entry DOI: 10.7270/Q2MC91RP
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311888 (US10166214, Example 24 | US10675268, Example 24 | ...) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1nccc2ccccc12 |r| Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)15-13-9-19-10-14(13)15)16-12-6-4-3-5-11(12)7-8-20-16/h3-8,13-15,19H,9-10H2,1-2H3,(H,21,22)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.5	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50597581 (CHEMBL5183772) Show SMILES COc1cccc(Cc2nnc(Cc3c[nH]c4ccccc34)n2CCCc2c[nH]cn2)c1 Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	0.5	n/a	n/a	n/a	n/a
TBA									Citation and Details Article DOI: 10.1039/d1md00044f BindingDB Entry DOI: 10.7270/Q21C21X0
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311941 (US10166214, Example 77 | US10675268, Example 77) Show SMILES Cc1nnc(c2ccccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C18H22N4O/c1-10-11-6-4-5-7-12(11)16(22-21-10)18(2,3)20-17(23)15-13-8-19-9-14(13)15/h4-7,13-15,19H,8-9H2,1-3H3,(H,20,23)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.5	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311941 (US10166214, Example 77 | US10675268, Example 77) Show SMILES Cc1nnc(c2ccccc12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C18H22N4O/c1-10-11-6-4-5-7-12(11)16(22-21-10)18(2,3)20-17(23)15-13-8-19-9-14(13)15/h4-7,13-15,19H,8-9H2,1-3H3,(H,20,23)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.5	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10166214 (2019) BindingDB Entry DOI: 10.7270/Q2D50Q16
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM311888 (US10166214, Example 24 | US10675268, Example 24 | ...) Show SMILES CC(C)(NC(=O)[C@@H]1[C@H]2CNC[C@@H]12)c1nccc2ccccc12 |r| Show InChI InChI=1S/C18H21N3O/c1-18(2,21-17(22)15-13-9-19-10-14(13)15)16-12-6-4-3-5-11(12)7-8-20-16/h3-8,13-15,19H,9-10H2,1-2H3,(H,21,22)/t13-,14+,15+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.5	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM50546560 (CHEMBL4778342) Show SMILES CN(C[C@@H]1CCCN1)Cc1c(cnc2ncn(-c3cc(O)cc(F)c3)c(=O)c12)-c1cc(C)cc(Cl)c1 |r| Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	0.501	n/a	n/a	n/a	n/a
TBA					Assay Description Agonist activity at human SST4				Citation and Details Article DOI: 10.1016/j.bmcl.2020.127496 BindingDB Entry DOI: 10.7270/Q2183B4R
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM312015 (US10166214, Example 151 | US10675268, Example 151) Show SMILES Cc1nc(n2cccc(F)c12)C(C)(C)NC(=O)[C@@H]1[C@H]2CNC[C@@H]12 |r| Show InChI InChI=1S/C17H21FN4O/c1-9-14-12(18)5-4-6-22(14)16(20-9)17(2,3)21-15(23)13-10-7-19-8-11(10)13/h4-6,10-11,13,19H,7-8H2,1-3H3,(H,21,23)/t10-,11+,13+	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.600	n/a	n/a	n/a	n/a
Centrexion Therapeutics Corporation US Patent					Assay Description The activation of the SSTR4 receptor (Gi coupled) causes an inhibition of intracellular cAMP after stimulation with Forskolin, which can be quantifia...				US Patent US10675268 (2020) BindingDB Entry DOI: 10.7270/Q21C20XK
					More data for this Ligand-Target Pair
Somatostatin receptor type 4 (Homo sapiens (Human))	BDBM523754 (US11136312, Compound MM-I-66) Show SMILES FC(F)(F)c1cccc(Cc2nnc(Cc3c[nH]c4ccccc34)n2CCCc2c[nH]cn2)c1 Show InChI	PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	0.600	n/a	n/a	n/a	n/a
TBA									Citation and Details Article DOI: 10.1039/d1md00044f BindingDB Entry DOI: 10.7270/Q21C21X0
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 1029 total )  |  Next  |  Last  >>

Jump to: